Quick Answer
MAXCYTE, INC. reported Stockholders Equity of $171.49 million for fiscal year 2025.
MAXCYTE, INC. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $171.49M | -16.9% |
| 2024 | $206.25M | -11.2% |
| 2023 | $232.17M | -8.6% |
| 2022 | $253.97M | -3.4% |
| 2021 | $262.90M | +691.3% |
| 2020 | $33.23M | +144.3% |
| 2019 | $13.60M | +10.7% |
| 2018 | $12.28M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $180.28M | -15.5% | -5.5% |
| June 30, 2025 | $190.72M | -13.8% | -4.4% |
| March 31, 2025 | $199.41M | -11.9% | -3.3% |
| December 31, 2024 | $206.25M | -11.2% | -3.3% |
| September 30, 2024 | $213.30M | -8.6% | -3.6% |
| June 30, 2024 | $221.26M | -8.2% | -2.3% |
| March 31, 2024 | $226.36M | -8.7% | -2.5% |
| December 31, 2023 | $232.17M | -8.6% | -0.5% |
- MAXCYTE, INC. showed a decrease of -16.9% in Stockholders Equity compared to the prior fiscal year.
- Over the 2018–2025 period, MAXCYTE, INC.’s stockholders equity has grown by 1296.3% (from $12.28 million to $171.49 million).
- The most recent figure is from MAXCYTE, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: